Our Services
Medical Information
Helpful Resources
Published on: 5/6/2026
Semaglutide for Weight Loss: What to Know
Semaglutide is an FDA-approved GLP-1 receptor agonist that helps eligible adults lose weight. In large clinical trials, patients lost an average of 10% to 15% of their body weight when semaglutide was combined with a reduced-calorie diet and increased physical activity.
Key considerations before starting semaglutide:
Because weight gain can stem from many underlying causes — from thyroid issues to insulin resistance to medication side effects — semaglutide isn't the right answer for everyone. Before pursuing any prescription treatment, it's smart to understand what's actually driving your symptoms. Take a free, instant, online symptom check to get personalized insight into your health and confidently navigate your next steps.
Reviewed for medical accuracy: 07/10/2026
Losing weight is seldom straightforward. You may have tried cutting calories, joining a gym, or following the latest diet trend—only to hit a plateau. If you've exhausted lifestyle tweaks and still see minimal progress, you're not alone. Recent advances in medicine offer new tools like semaglutide for weight loss, but it's important to understand what this treatment really entails and how to move forward safely.
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist originally approved for Type 2 diabetes. Under higher doses and a different brand name, it's now FDA-approved specifically for chronic weight management in adults with:
By mimicking a naturally occurring gut hormone, semaglutide helps regulate appetite and food intake.
Semaglutide targets key mechanisms that influence eating behavior:
Clinical trials report average weight loss of 10–15% of initial body weight over 68 weeks when combined with a reduced-calorie diet and increased physical activity.
Several large, peer-reviewed trials—commonly called the STEP trials—support semaglutide's benefits:
These studies, published in leading journals, demonstrate that semaglutide can be a powerful adjunct to lifestyle intervention.
Semaglutide isn't a one-size-fits-all solution. Ideal candidates typically:
It's not recommended if you're pregnant, have certain gastrointestinal conditions, or a personal/family history of medullary thyroid carcinoma.
Like any medication, semaglutide comes with possible side effects. The most common are gastrointestinal and usually temporary:
To minimize discomfort, your doctor will start at a low dose and slowly increase over weeks. Rare but serious risks include pancreatitis and gallbladder disease. Always report severe abdominal pain or persistent vomiting.
Semaglutide works best when paired with sustainable habits. Consider these medically approved strategies:
• Dietary patterns
Not sure where to start? Take Ubie's free AI symptom checker to assess your current health concerns and get personalized guidance on whether weight-loss interventions like semaglutide might be appropriate for your individual situation.
While semaglutide offers promise, it's crucial to maintain open communication with a healthcare professional. If you experience any of the following, seek medical advice promptly:
Always speak to a doctor about anything that could be life threatening or serious.
Semaglutide for weight loss represents a significant advance in obesity treatment. It's not a miracle cure, but when combined with proven lifestyle changes, it can help many people achieve—and maintain—a healthier weight. Remember:
By understanding how semaglutide works, knowing the evidence, and following medically approved next steps, you can make informed decisions on your path to better health.
(References)
* Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021 Mar 18;384(11):989-1002. doi: 10.1056/NEJMoa2032183. PMID: 33567136.
* Rubino DM, Abrahamsson N, Davies M, et al. Effect of Once-Weekly Semaglutide on Maintenance of Weight Loss in Adults with Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA. 2021 Apr 13;325(14):1414-1422. doi: 10.1001/jama.2021.3224. PMID: 33764377.
* Ryan DH, Lingvay I, Belentani-Zuanetti M, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity, and Comorbidities. N Engl J Med. 2021 Mar 18;384(11):1003-1014. doi: 10.1056/NEJMoa2032283. PMID: 33567137.
* Vilsbøll T, Lingvay I, Bergenstal RM, et al. Efficacy and Safety of Once-Weekly Semaglutide in Adults With Overweight or Obesity, and Nonalcoholic Steatohepatitis: The STEP 5 Randomized Clinical Trial. Gastroenterology. 2023 Feb;164(2):220-231.e9. doi: 10.1053/j.gastro.2022.10.026. PMID: 36343734.
* Kushner RF, Calanna S, Davies M, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity, and Type 2 Diabetes. N Engl J Med. 2022 May 19;386(20):1961-1972. doi: 10.1056/NEJMoa2202688. PMID: 35587123.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.